Overcoming Drug Discovery Challenges Through AI-Driven Innovation

The Integration of START and CURC Could Play a Pivotal Role in Advancing Clinical Trials

The V Foundation for Cancer Research and CVC Partner to Accelerate Breast Cancer Vaccines

Ferroptosis as a New Strategy: Iron-Driven Cell Death Targets Cancer Stem Cells

Redesigned CD40 Antibody Triggers Systemic Tumor Regression and Complete Remission

RNA Isoform RUNX1C Identified as Molecular 'Switch' Behind Chemoresistance in Blood Cancer

Bacteria Cloak Viruses to Safely Deliver Cancer-Killing Payloads into Solid Tumors

Genetic Testing Boosts Safety, Reduces Chemotherapy Side Effects in GI Cancer

New Study Uncovers Hidden Disease in 42% of Ovarian Cancer Patients in Remission

New Radioimmunotherapy Strategy Eradicates Cancer Stem Cells in Ovarian Cancer

Dr. Iris Kuss: ARANOTE Trial Results Signal a New Era in Prostate Cancer Treatment

Global Data Warns of Secondary Cancers Linked to CAR-T Therapy, Urging Monitoring

Supercharging Chemotherapy with a Mitochondrial Strategy for Lung Cancer Treatment

Advancing ADCs and Bispecifics Across Oncology and Immunology

How SkinJect’s Microneedle-Patch Could Improve Skin Cancer Treatment Outcomes

Promising Targeted Immunotherapy Improves Survival in HPV16+ Cancers

Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors

Shining a Light on Lung Cancer: The Promise of Abenacianine

How to Improve Access to CAR T-cell Therapy: The Role of Policy and Innovation

Overcoming Challenges and Expanding Access to CAR T-Cell Therapy

A Patient Advocacy Perspective on Expanding Access to CAR T-cell Therapy

AMPLITUDE: Niraparib Combo Improves rPFS in HRR-Altered mCS Prostate Cancer

Enhertu-pertuzumab Combo Shows 44% Risk Reduction in HER2+ Breast Cancer

FDA Approves Darolutamide Plus ADT for mCS Prostate Cancer

ctDNA-Guided Camizestrant Switch Redefines 1st-Line Breast Cancer Treatment

World-First Clinical Trial Confirms Exercise Boosts Survival in Colon Cancer

How the Integration of START and CURC Is Advancing Cancer Research and Clinical Trials

EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer

Oncologists Struggle with Innovation Overload: 'The Growing Chasm in Cancer Care'

New AI-Powered Urine Test Detects Prostate Cancer with Higher Precision than PSA

How SkinJect's Microneedle Technology Could Transform the Treatment of Skin Cancer

A Breakthrough in Personalizing Lung Cancer Therapy with the GO Chip for Tumor Monitoring

The Next Generation of ADCs and Their Potential for Non-Small Cell Lung Cancer

How Bayer Shapes Strategic Partnerships for the Next Generation of Cancer Therapies

How AI Innovations Are Transforming Breast Cancer Screening

Dr. Rafael Rosell Discusses the Efficacy of KRAS G12C Inhibitor in Lung Cancer Treatment

How AI Could Overcome Data Scarcity to Transform Medicine

The Recombinant Polyclonal Drug Candidate GIGA-2339 for Hepatitis B Treatment

How Qvin's Q-Pad Could Transform Women’s Health Through Menstrual Blood Testing

Palbociclib Combination Yields PFS Improvement in HR+, HER2+ Breast Cancer

Olaparib Shows Long-term Survival Benefits in BRCA+ and HER2- Breast Cancer

Fixed-Duration Acalabrutinib Plus Venetoclax Achieves Superior 77% PFS in Untreated CLL

How AI is Shaping Drug Discovery: LP-300 in Lung Cancer Treatment

How Novel Immunotherapy IMNN-001 Could Change Ovarian Cancer Outcomes

How Oncolytic Viruses Could Be a New Frontier in Transforming Cancer Treatment

Overcoming Resistance in Cancer Treatment with Cytokine Therapies

Novel Biomarker-Driven Treatments with ADCs in NSC Lung Cancer Management

Role of CGP Testing in the Management of Cancer Treatment and Personalized Care

Transforming Melanoma Treatment with DNA Plasmid Vaccine

Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global